ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$58.16
+0.70 (+1.22%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
+19.5% upside
Low Target
$62.98
Average Target
$69.50
High Target
$88.85
Current Price
$58.16
Current
$58.16
$58.16
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Scenario Analysis
Bear Case
$62.98
8.3%
Low target
Base Case
$69.50
+19.5%
Avg target
Bull Case
$88.85
+52.8%
High target
Risk/Reward
6.4x
Highly favorable
Price in Context
52-Week High
$95.49
-39.1% from high
52-Week Low
$37.06
+56.9% from low
50-Day SMA
$66.91
-13.1% vs SMA
200-Day SMA
$71.55
-18.7% vs SMA
RSI (14)
53.6
Neutral
Target vs 52W High
$69.50
-27.2% vs high
Next Earnings Report
Nov 12, 2026 · After Market Close
4d
until earnings
EPS Est: $-1.62
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |